Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  polyvalent melanoma vaccine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-5 of 5 for your search:
Start Over
Phase III Randomized Study of Immunotherapy With Polyvalent Melanoma Vaccine (Canvaxin™) Plus BCG Versus BCG Plus Placebo After Surgery in Patients With Stage IV Melanoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: NCI
Protocol IDs: JWCI-MC-4-001, CV-MMAIT-4-001, RPCI-DS-98-16, NCI-G98-1492, NCT00052156
Phase III Randomized Study of BCG Plus a Polyvalent Melanoma Vaccine (Canvaxin™) Versus BCG Plus Placebo in Patients With Resected Stage III Melanoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: NCI
Protocol IDs: JWCI-MC-3-001A, CV-MMAIT-3-001, NCI-V99-1576, NCT00052130
Vaccine Therapy Plus Interleukin-2 With or Without Interferon Alfa-2b in Treating Patients With Stage III Melanoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: NCI, Other
Protocol IDs: CDR0000067323, NYU-9837, NCI-G99-1595, NCT00004104
Start Over